347 related articles for article (PubMed ID: 18679021)
21. Pancreatic neuroendocrine tumor associated with humoral hypercalcemia of malignancy and carcinoid tumor: a case report and review of the literature.
Shah RH; Martinez D
Pancreas; 2013 Apr; 42(3):549-51. PubMed ID: 23211368
[No Abstract] [Full Text] [Related]
22. Hypercalcaemia in a patient with fatal adenosquamous carcinoma of the colon.
Links M; Ho H; Clingan P; Diamond T
Med J Aust; 1994 Mar; 160(5):286-7. PubMed ID: 8107631
[TBL] [Abstract][Full Text] [Related]
23. Parathyroid hormone-related protein in pancreatic exocrine cancer associated with hypercalcaemia.
Bandyopadhyay P; Baksi S; Bandyopadhyay D; Patel CU
Int J Clin Pract; 2003 Mar; 57(2):140-2. PubMed ID: 12661799
[TBL] [Abstract][Full Text] [Related]
24. A rare case of chronic lymphocytic leukemia with hypercalcemia induced by elevated parathyroid hormone-related peptides.
Kampfenkel T; Baraniskin A; Teschendorf C; Schmiegel W; Massenkeil G
Acta Haematol; 2010; 124(1):57-60. PubMed ID: 20616540
[TBL] [Abstract][Full Text] [Related]
25. Parathyroid hormone-related peptide as a cause of hypercalcemia in squamous cell carcinoma of the head and neck: a case presentation and subject review.
Brawner JT; Zitsch RP
Head Neck; 2004 Apr; 26(4):382-4. PubMed ID: 15054743
[TBL] [Abstract][Full Text] [Related]
26. Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia.
Kanakis G; Kaltsas G; Granberg D; Grimelius L; Papaioannou D; Tsolakis AV; Öberg K
J Clin Endocrinol Metab; 2012 Apr; 97(4):E627-31. PubMed ID: 22319031
[TBL] [Abstract][Full Text] [Related]
27. Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours.
Srirajaskanthan R; Toumpanakis C; Meyer T; Caplin ME
Aliment Pharmacol Ther; 2009 Jun; 29(11):1143-54. PubMed ID: 19298583
[TBL] [Abstract][Full Text] [Related]
28. Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET).
Symington M; Davies L; Kaltsas G; Weickert MO
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28331027
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic neuroendocrine tumours.
Alexakis N; Neoptolemos JP
Best Pract Res Clin Gastroenterol; 2008; 22(1):183-205. PubMed ID: 18206821
[TBL] [Abstract][Full Text] [Related]
30. PTHrP and PTH/PTHrP receptor 1 expression in odontogenic cells of normal and HHM model rat incisors.
Kato A; Suzuki M; Karasawa Y; Sugimoto T; Doi K
Toxicol Pathol; 2005; 33(4):456-64. PubMed ID: 16036863
[TBL] [Abstract][Full Text] [Related]
31. Hypercalcemia induced by ovarian clear cell carcinoma producing all transcriptional variants of parathyroid hormone-related peptide gene during pregnancy.
Hwang CS; Park SY; Yu SH; Park JY; Park CT; Han KO
Gynecol Oncol; 2006 Nov; 103(2):740-4. PubMed ID: 16956653
[TBL] [Abstract][Full Text] [Related]
32. Duodeno-pancreatic neuroendocrine tumours.
Peros G; Sakorafas GH; Konstantoudakis G; Giannopoulos GA; Petropoulou K; Parasi A
Eur J Cancer Care (Engl); 2010 May; 19(3):393-402. PubMed ID: 19708940
[TBL] [Abstract][Full Text] [Related]
33. Medical management of pancreatic neuroendocrine tumors.
Delaunoit T; Neczyporenko F; Rubin J; Erlichman C; Hobday TJ
Am J Gastroenterol; 2008 Feb; 103(2):475-83; quiz 484. PubMed ID: 18028508
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone-related protein-secreting uterine endometrioid adenocarcinoma.
Kinugasa Y; Morishige K; Kamiura S; Tsukamoto Y; Saji F
Jpn J Clin Oncol; 2006 Feb; 36(2):113-5. PubMed ID: 16418186
[TBL] [Abstract][Full Text] [Related]
35. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
[TBL] [Abstract][Full Text] [Related]
36. Acute pancreatitis secondary to pancreatic neuroendocrine tumours.
Griñó P; Martínez J; Griñó E; Carnicer F; Alonso S; Pérez-Berenguer H; Pérez-Mateo M
JOP; 2003 Mar; 4(2):104-10. PubMed ID: 12629267
[TBL] [Abstract][Full Text] [Related]
37. Morphological changes in the parathyroid gland of rats with humoral hypercalcaemia of malignancy.
Nakanishi M; Sawamoto O; Kawashima M; Kuwamura M; Yamate J
J Comp Pathol; 2004 Jul; 131(1):92-7. PubMed ID: 15144804
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
39. Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.
Blind E; Raue F; Götzmann J; Schmidt-Gayk H; Kohl B; Ziegler R
Clin Endocrinol (Oxf); 1992 Sep; 37(3):290-7. PubMed ID: 1424212
[TBL] [Abstract][Full Text] [Related]
40. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.
Nakajima K; Tamai M; Okaniwa S; Nakamura Y; Kobayashi M; Niwa T; Horigome N; Ito N; Suzuki S; Nishio S; Komatsu M
Endocr J; 2013; 60(5):557-62. PubMed ID: 23303131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
